The UtroDMD Alliance is a multi-year strategic collaboration that aims to accelerate the development of first and future generation utrophin modulator therapies for the treatment of all patients with DMD. This Alliance combines the extensive biology, chemistry and drug discovery and development expertise of Summit and the University of Oxford and is being supported by the Medical Research Council and Muscular Dystrophy Campaign.
For more information about the UtroDMD Alliance partners:
University of Oxford: http://www.ox.ac.uk
Muscular Dystrophy UK: http://www.musculardystrophyuk.org/
Medical Research Council: http://www.mrc.ac.uk